Amsterdam

• The RJVA-001 First in Human Trial in Adults with Inadequately Controlled Type 2 Diabetes. Pending
  2025-524438-24-00 7 Type 2 Diabetes
• Comparison of standard abiraterone dosing and dosing based on abiraterone blood levels Pending
  2025-524440-35-00 6 metastatic castration resistant prostate cancer (mCRPC)
• A clinical study investigating modafinil for the treatment of severe fatigue in patients with inflammatory bowel disease (MODIFI-IBD trial) Pending
  2026-525163-41-00 10 Inflammatory bowel disease
• Clinical trial to evaluate the safety, tolerability and effectiveness of a medicinal nasal insert in the treatment of chronic hay fever.- In … Pending
  2026-525200-99-00 1 Chronic allergic rhinitis
• PLUTO Pending
  2026-525211-14-00 4 HIV-1
• A Phase 3 Study Comparing JNJ-79635322 and an anti-BCMAxCD3 Bispecific Antibody in Participants with Relapsed or Refractory Multiple Myeloma Recruiting
  2025-522007-18-00 5 2026-05-27 Relapsed or Refractory Multiple Myeloma
• Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial Recruiting
  2025-522128-28-00 3 2026-05-26 Breast cancer
• Study to assess the efficacy and safety of Rina-S in participants with non-small cell lung cancer Recruiting
  2025-522107-18-00 4 2026-05-19 Locally advanced or metastatic Non-Small Cell Lung Cancer
• A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043) Recruiting
  2025-524160-38-00 5 2026-05-12 Renal Cell Carcinoma, hepatocellular carcinoma, nonMSI-H/dMMR colorect
• An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting
  2024-519870-38-00 5 2026-05-11 Atherosclerotic cardiovascular disease (ASCVD)
• A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight without type 2 diabetes. Recruiting
  2025-523104-71-00 5 2026-05-08 Obesity or Overweight Without Type 2 Diabetes
• Study to Evaluate the Efficacy and Safety of Deucrictibant for Prophylactic and On-demand Treatment of Angioedema Attacks in Adults with Acq … Recruiting
  2025-522051-26-00 5 2026-04-23 Acquired Angioedema due to C1 Inhibitor Deficiency
• Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting
  2025-522878-36-00 5 2026-04-20 Chronic Spontaneous Urticaria
• A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting
  2025-522191-86-00 5 2026-04-02 Focal segmental glomerulosclerosis
• A Long-term Study of Navenibart in Participants with Hereditary Angioedema Recruiting
  2025-521142-22-00 5 2026-03-27 Hereditary Angioedema
• ROSETTA Breast-01: The effects and safety of pumitamig in patients with triple-negative breast cancer Recruiting
  2025-521884-12-00 5 2026-03-19 First line triple-negative breast cancer (TNBC)
• A clinical study of MK-3120 in people with bladder cancer (MK-3120-003) Recruiting
  2025-520467-40-00 9 2026-03-16 High-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in
• A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies Recruiting
  2024-516476-15-00 9 2026-03-04 Advanced gastrointestinal stromal tumor (GIST)
• A Phase III Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients with Recurrent Glioblastoma Recruiting
  2025-521785-10-00 5 2026-03-04 Glioblastoma
• TADalafil in early-stage Parkinson’s Disease (TAD-PD) Recruiting
  2025-521819-39-00 4 2026-03-02 Parkinson's disease
• A Study to assess the Safety, Tolerability and effect of RO7673396 when used alone as well as with other cancer medications in participants … Recruiting
  2024-519622-20-00 1 2026-02-27 Advanced Solid Tumors Harboring RAS Mutation(S)
• A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting
  2025-522553-19-00 10 2026-02-25 Symptomatic genetic and familial dilated cardiomyopathy.
• First-in-Human Study of RO7812653 Recruiting
  2025-522101-37-00 1 2026-02-17 Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cognitive Impairmen
• A clinical study of enlicitide in children with high cholesterol (MK-0616-029) Recruiting
  2024-519068-42-00 10 2026-02-12 ​Heterozygous Familial Hypercholesterolemia​ in pediatric patients

Showing 97–120 of 1,112 trials